Cell Therapy CDMO Market Size, Share 2023

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 Cell Therapy CDMO Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cell Therapy CDMO Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cell Therapy CDMO Overall Market Size
2.1 Global Cell Therapy CDMO Market Size: 2022 VS 2032
2.2 Global Cell Therapy CDMO Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cell Therapy CDMO Players in Global Market
3.2 Top Global Cell Therapy CDMO Companies Ranked by Revenue
3.3 Global Cell Therapy CDMO Revenue by Companies
3.4 Top 3 and Top 5 Cell Therapy CDMO Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cell Therapy CDMO Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cell Therapy CDMO Players in Global Market
3.6.1 List of Global Tier 1 Cell Therapy CDMO Companies
3.6.2 List of Global Tier 2 and Tier 3 Cell Therapy CDMO Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Cell Therapy CDMO Market Size Markets, 2022 & 2032
4.1.2 Stem Cell
4.1.3 Non-Stem Cell
4.2 By Type - Global Cell Therapy CDMO Revenue & Forecasts
4.2.1 By Type - Global Cell Therapy CDMO Revenue, 2018-2023
4.2.2 By Type - Global Cell Therapy CDMO Revenue, 2023-2032
4.2.3 By Type - Global Cell Therapy CDMO Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cell Therapy CDMO Market Size, 2022 & 2032
5.1.2 Commercial
5.1.3 Academic Research
5.1.4 Others
5.2 By Application - Global Cell Therapy CDMO Revenue & Forecasts
5.2.1 By Application - Global Cell Therapy CDMO Revenue, 2018-2023
5.2.2 By Application - Global Cell Therapy CDMO Revenue, 2023-2032
5.2.3 By Application - Global Cell Therapy CDMO Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Cell Therapy CDMO Market Size, 2022 & 2032
6.2 By Region - Global Cell Therapy CDMO Revenue & Forecasts
6.2.1 By Region - Global Cell Therapy CDMO Revenue, 2018-2023
6.2.2 By Region - Global Cell Therapy CDMO Revenue, 2023-2032
6.2.3 By Region - Global Cell Therapy CDMO Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Cell Therapy CDMO Revenue, 2018-2032
6.3.2 US Cell Therapy CDMO Market Size, 2018-2032
6.3.3 Canada Cell Therapy CDMO Market Size, 2018-2032
6.3.4 Mexico Cell Therapy CDMO Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Cell Therapy CDMO Revenue, 2018-2032
6.4.2 Germany Cell Therapy CDMO Market Size, 2018-2032
6.4.3 France Cell Therapy CDMO Market Size, 2018-2032
6.4.4 U.K. Cell Therapy CDMO Market Size, 2018-2032
6.4.5 Italy Cell Therapy CDMO Market Size, 2018-2032
6.4.6 Russia Cell Therapy CDMO Market Size, 2018-2032
6.4.7 Nordic Countries Cell Therapy CDMO Market Size, 2018-2032
6.4.8 Benelux Cell Therapy CDMO Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Cell Therapy CDMO Revenue, 2018-2032
6.5.2 China Cell Therapy CDMO Market Size, 2018-2032
6.5.3 Japan Cell Therapy CDMO Market Size, 2018-2032
6.5.4 South Korea Cell Therapy CDMO Market Size, 2018-2032
6.5.5 Southeast Asia Cell Therapy CDMO Market Size, 2018-2032
6.5.6 India Cell Therapy CDMO Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Cell Therapy CDMO Revenue, 2018-2032
6.6.2 Brazil Cell Therapy CDMO Market Size, 2018-2032
6.6.3 Argentina Cell Therapy CDMO Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cell Therapy CDMO Revenue, 2018-2032
6.7.2 Turkey Cell Therapy CDMO Market Size, 2018-2032
6.7.3 Israel Cell Therapy CDMO Market Size, 2018-2032
6.7.4 Saudi Arabia Cell Therapy CDMO Market Size, 2018-2032
6.7.5 UAE Cell Therapy CDMO Market Size, 2018-2032
7 Players Profiles
7.1 Charles River
7.1.1 Charles River Corporate Summary
7.1.2 Charles River Business Overview
7.1.3 Charles River Cell Therapy CDMO Major Product Offerings
7.1.4 Charles River Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.1.5 Charles River Key News
7.2 The Discovery Labs
7.2.1 The Discovery Labs Corporate Summary
7.2.2 The Discovery Labs Business Overview
7.2.3 The Discovery Labs Cell Therapy CDMO Major Product Offerings
7.2.4 The Discovery Labs Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.2.5 The Discovery Labs Key News
7.3 BIOCENTRIQ
7.3.1 BIOCENTRIQ Corporate Summary
7.3.2 BIOCENTRIQ Business Overview
7.3.3 BIOCENTRIQ Cell Therapy CDMO Major Product Offerings
7.3.4 BIOCENTRIQ Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.3.5 BIOCENTRIQ Key News
7.4 FUJIFILM Diosynth Biotechnologies
7.4.1 FUJIFILM Diosynth Biotechnologies Corporate Summary
7.4.2 FUJIFILM Diosynth Biotechnologies Business Overview
7.4.3 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Major Product Offerings
7.4.4 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.4.5 FUJIFILM Diosynth Biotechnologies Key News
7.5 Exothera
7.5.1 Exothera Corporate Summary
7.5.2 Exothera Business Overview
7.5.3 Exothera Cell Therapy CDMO Major Product Offerings
7.5.4 Exothera Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.5.5 Exothera Key News
7.6 WuXi AppTec
7.6.1 WuXi AppTec Corporate Summary
7.6.2 WuXi AppTec Business Overview
7.6.3 WuXi AppTec Cell Therapy CDMO Major Product Offerings
7.6.4 WuXi AppTec Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.6.5 WuXi AppTec Key News
7.7 Pharmaron
7.7.1 Pharmaron Corporate Summary
7.7.2 Pharmaron Business Overview
7.7.3 Pharmaron Cell Therapy CDMO Major Product Offerings
7.7.4 Pharmaron Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.7.5 Pharmaron Key News
7.8 OBiO
7.8.1 OBiO Corporate Summary
7.8.2 OBiO Business Overview
7.8.3 OBiO Cell Therapy CDMO Major Product Offerings
7.8.4 OBiO Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.8.5 OBiO Key News
7.9 Cell Therapies
7.9.1 Cell Therapies Corporate Summary
7.9.2 Cell Therapies Business Overview
7.9.3 Cell Therapies Cell Therapy CDMO Major Product Offerings
7.9.4 Cell Therapies Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.9.5 Cell Therapies Key News
7.10 AGC Biologics
7.10.1 AGC Biologics Corporate Summary
7.10.2 AGC Biologics Business Overview
7.10.3 AGC Biologics Cell Therapy CDMO Major Product Offerings
7.10.4 AGC Biologics Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.10.5 AGC Biologics Key News
7.11 Cytiva
7.11.1 Cytiva Corporate Summary
7.11.2 Cytiva Business Overview
7.11.3 Cytiva Cell Therapy CDMO Major Product Offerings
7.11.4 Cytiva Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.11.5 Cytiva Key News
7.12 Helixmith
7.12.1 Helixmith Corporate Summary
7.12.2 Helixmith Business Overview
7.12.3 Helixmith Cell Therapy CDMO Major Product Offerings
7.12.4 Helixmith Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.12.5 Helixmith Key News
7.13 ThermoGenesis
7.13.1 ThermoGenesis Corporate Summary
7.13.2 ThermoGenesis Business Overview
7.13.3 ThermoGenesis Cell Therapy CDMO Major Product Offerings
7.13.4 ThermoGenesis Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.13.5 ThermoGenesis Key News
7.14 Anemocyte
7.14.1 Anemocyte Corporate Summary
7.14.2 Anemocyte Business Overview
7.14.3 Anemocyte Cell Therapy CDMO Major Product Offerings
7.14.4 Anemocyte Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.14.5 Anemocyte Key News
7.15 Thermo Fisher Scientific
7.15.1 Thermo Fisher Scientific Corporate Summary
7.15.2 Thermo Fisher Scientific Business Overview
7.15.3 Thermo Fisher Scientific Cell Therapy CDMO Major Product Offerings
7.15.4 Thermo Fisher Scientific Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.15.5 Thermo Fisher Scientific Key News
7.16 CBM
7.16.1 CBM Corporate Summary
7.16.2 CBM Business Overview
7.16.3 CBM Cell Therapy CDMO Major Product Offerings
7.16.4 CBM Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.16.5 CBM Key News
7.17 Bio Elpida
7.17.1 Bio Elpida Corporate Summary
7.17.2 Bio Elpida Business Overview
7.17.3 Bio Elpida Cell Therapy CDMO Major Product Offerings
7.17.4 Bio Elpida Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.17.5 Bio Elpida Key News
7.18 Genezen
7.18.1 Genezen Corporate Summary
7.18.2 Genezen Business Overview
7.18.3 Genezen Cell Therapy CDMO Major Product Offerings
7.18.4 Genezen Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.18.5 Genezen Key News
7.19 CCRM
7.19.1 CCRM Corporate Summary
7.19.2 CCRM Business Overview
7.19.3 CCRM Cell Therapy CDMO Major Product Offerings
7.19.4 CCRM Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.19.5 CCRM Key News
7.20 RoslinCT
7.20.1 RoslinCT Corporate Summary
7.20.2 RoslinCT Business Overview
7.20.3 RoslinCT Cell Therapy CDMO Major Product Offerings
7.20.4 RoslinCT Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.20.5 RoslinCT Key News
7.21 GenScript ProBio
7.21.1 GenScript ProBio Corporate Summary
7.21.2 GenScript ProBio Business Overview
7.21.3 GenScript ProBio Cell Therapy CDMO Major Product Offerings
7.21.4 GenScript ProBio Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.21.5 GenScript ProBio Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Cell Therapy CDMO Market Opportunities & Trends in Global Market
Table 2. Cell Therapy CDMO Market Drivers in Global Market
Table 3. Cell Therapy CDMO Market Restraints in Global Market
Table 4. Key Players of Cell Therapy CDMO in Global Market
Table 5. Top Cell Therapy CDMO Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cell Therapy CDMO Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cell Therapy CDMO Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cell Therapy CDMO Product Type
Table 9. List of Global Tier 1 Cell Therapy CDMO Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cell Therapy CDMO Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cell Therapy CDMO Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Cell Therapy CDMO Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cell Therapy CDMO Revenue in Global (US$, Mn), 2023-2032
Table 14. By Application ? Global Cell Therapy CDMO Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Cell Therapy CDMO Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cell Therapy CDMO Revenue in Global (US$, Mn), 2023-2032
Table 17. By Region ? Global Cell Therapy CDMO Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Cell Therapy CDMO Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cell Therapy CDMO Revenue (US$, Mn), 2023-2032
Table 20. By Country - North America Cell Therapy CDMO Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cell Therapy CDMO Revenue, (US$, Mn), 2023-2032
Table 22. By Country - Europe Cell Therapy CDMO Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cell Therapy CDMO Revenue, (US$, Mn), 2023-2032
Table 24. By Region - Asia Cell Therapy CDMO Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cell Therapy CDMO Revenue, (US$, Mn), 2023-2032
Table 26. By Country - South America Cell Therapy CDMO Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cell Therapy CDMO Revenue, (US$, Mn), 2023-2032
Table 28. By Country - Middle East & Africa Cell Therapy CDMO Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cell Therapy CDMO Revenue, (US$, Mn), 2023-2032
Table 30. Charles River Corporate Summary
Table 31. Charles River Cell Therapy CDMO Product Offerings
Table 32. Charles River Cell Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 33. The Discovery Labs Corporate Summary
Table 34. The Discovery Labs Cell Therapy CDMO Product Offerings
Table 35. The Discovery Labs Cell Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 36. BIOCENTRIQ Corporate Summary
Table 37. BIOCENTRIQ Cell Therapy CDMO Product Offerings
Table 38. BIOCENTRIQ Cell Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 39. FUJIFILM Diosynth Biotechnologies Corporate Summary
Table 40. FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Product Offerings
Table 41. FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 42. Exothera Corporate Summary
Table 43. Exothera Cell Therapy CDMO Product Offerings
Table 44. Exothera Cell Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 45. WuXi AppTec Corporate Summary
Table 46. WuXi AppTec Cell Therapy CDMO Product Offerings
Table 47. WuXi AppTec Cell Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 48. Pharmaron Corporate Summary
Table 49. Pharmaron Cell Therapy CDMO Product Offerings
Table 50. Pharmaron Cell Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 51. OBiO Corporate Summary
Table 52. OBiO Cell Therapy CDMO Product Offerings
Table 53. OBiO Cell Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 54. Cell Therapies Corporate Summary
Table 55. Cell Therapies Cell Therapy CDMO Product Offerings
Table 56. Cell Therapies Cell Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 57. AGC Biologics Corporate Summary
Table 58. AGC Biologics Cell Therapy CDMO Product Offerings
Table 59. AGC Biologics Cell Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 60. Cytiva Corporate Summary
Table 61. Cytiva Cell Therapy CDMO Product Offerings
Table 62. Cytiva Cell Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 63. Helixmith Corporate Summary
Table 64. Helixmith Cell Therapy CDMO Product Offerings
Table 65. Helixmith Cell Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 66. ThermoGenesis Corporate Summary
Table 67. ThermoGenesis Cell Therapy CDMO Product Offerings
Table 68. ThermoGenesis Cell Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 69. Anemocyte Corporate Summary
Table 70. Anemocyte Cell Therapy CDMO Product Offerings
Table 71. Anemocyte Cell Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 72. Thermo Fisher Scientific Corporate Summary
Table 73. Thermo Fisher Scientific Cell Therapy CDMO Product Offerings
Table 74. Thermo Fisher Scientific Cell Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 75. CBM Corporate Summary
Table 76. CBM Cell Therapy CDMO Product Offerings
Table 77. CBM Cell Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 78. Bio Elpida Corporate Summary
Table 79. Bio Elpida Cell Therapy CDMO Product Offerings
Table 80. Bio Elpida Cell Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 81. Genezen Corporate Summary
Table 82. Genezen Cell Therapy CDMO Product Offerings
Table 83. Genezen Cell Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 84. CCRM Corporate Summary
Table 85. CCRM Cell Therapy CDMO Product Offerings
Table 86. CCRM Cell Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 87. RoslinCT Corporate Summary
Table 88. RoslinCT Cell Therapy CDMO Product Offerings
Table 89. RoslinCT Cell Therapy CDMO Revenue (US$, Mn), (2018-2023)
Table 90. GenScript ProBio Corporate Summary
Table 91. GenScript ProBio Cell Therapy CDMO Product Offerings
Table 92. GenScript ProBio Cell Therapy CDMO Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Cell Therapy CDMO Segment by Type in 2022
Figure 2. Cell Therapy CDMO Segment by Application in 2022
Figure 3. Global Cell Therapy CDMO Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cell Therapy CDMO Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Cell Therapy CDMO Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cell Therapy CDMO Revenue in 2022
Figure 8. By Type - Global Cell Therapy CDMO Revenue Market Share, 2018-2032
Figure 9. By Application - Global Cell Therapy CDMO Revenue Market Share, 2018-2032
Figure 10. By Region - Global Cell Therapy CDMO Revenue Market Share, 2018-2032
Figure 11. By Country - North America Cell Therapy CDMO Revenue Market Share, 2018-2032
Figure 12. US Cell Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 13. Canada Cell Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 14. Mexico Cell Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 15. By Country - Europe Cell Therapy CDMO Revenue Market Share, 2018-2032
Figure 16. Germany Cell Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 17. France Cell Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 18. U.K. Cell Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 19. Italy Cell Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 20. Russia Cell Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 21. Nordic Countries Cell Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 22. Benelux Cell Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 23. By Region - Asia Cell Therapy CDMO Revenue Market Share, 2018-2032
Figure 24. China Cell Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 25. Japan Cell Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 26. South Korea Cell Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 27. Southeast Asia Cell Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 28. India Cell Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 29. By Country - South America Cell Therapy CDMO Revenue Market Share, 2018-2032
Figure 30. Brazil Cell Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 31. Argentina Cell Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 32. By Country - Middle East & Africa Cell Therapy CDMO Revenue Market Share, 2018-2032
Figure 33. Turkey Cell Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 34. Israel Cell Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 35. Saudi Arabia Cell Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 36. UAE Cell Therapy CDMO Revenue, (US$, Mn), 2018-2032
Figure 37. Charles River Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. The Discovery Labs Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. BIOCENTRIQ Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Exothera Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. WuXi AppTec Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Pharmaron Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. OBiO Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Cell Therapies Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AGC Biologics Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Cytiva Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Helixmith Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. ThermoGenesis Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Anemocyte Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Thermo Fisher Scientific Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. CBM Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Bio Elpida Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Genezen Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. CCRM Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. RoslinCT Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. GenScript ProBio Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

DOWNLOAD SAMPLE